Furthermore, the BCR-ABL signaling pathway was indeed activated in the IL-17A high subgroup and IL-17RA high subgroups of Ph+ B-ALL patients (Supplementary Fig. 4f, g). The gene discussed is ABL1; the disease is precursor B-cell acute lymphoblastic leukemia.